2Perlade DE Smulian AG Cushion MT.Molecular epidemiology and anti-biotic susceptible of Enterococci in Cincinnati, Ohio:a prospective cityside surgery[J].J Clin Microbiol,1997,35(9):2342-2342.
4Ballow CH, Jones RN, Biedenbach DJ et al. A multicenter evaluation of linezolid antimicrobial activity in North America.Diagn Microbiol Infect Dis, 2002,43(1) : 75-83.
5Murphy TM, Deitz JM, Petersen PJ, et al. Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental. Antimicrobial Agents and Chemotherapy, 2000,44( 11 ) : 3022-3027.
6Zhanel GG, Hoban DJ, Karlowsky JA. Nitrofurantoin Is Active against Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy,2001,233(2) :306-312.
7Zhanel GG, Laing NM, Nichol KA. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study(NAVRESS. J Antimicrob Chemother, 2003, 52 ( 3 ) : 382-8.Epub 2003 Jul 29.
8Koch S, Hufnagel M, Theilacker C. Huebner J Enterococcal infections., host response, therapeutic, and prophylactic possibilities. Vaccine, 2004,22 ( 7 ): 822-830.
